SDC1 and plasma cell myeloma: We examined miR-23b expression (Affymetrix, Santa Clara, CA, USA) in CD138+ myeloma cells from 38 MM patients and 18 plasma cell leukemia patients and found it to be downregulated compared with normal PCs (Figure 2a).